AG
CSCI

Advisor Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Advisor Group’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Sell
10
-5
-33% -$466 ﹤0.01% 5219
2019
Q3 		$1K Sell
15
-6
-29% -$1.3K ﹤0.01% 5190
2019
Q2 		$6K Buy
21
+6
+40% +$2.12K ﹤0.01% 4624
2019
Q1 		$7K Hold
15
– – ﹤0.01% 4551
2018
Q4 		$4K Buy
+15
New +$3.58K ﹤0.01% 4644
2018
Q3 		– Hold
0
– – – 5243
2018
Q2 		– Hold
0
– – – 5064
2018
Q1 		– Hold
0
– – – 5084
2017
Q4 		– Hold
0
– – – 5079
2017
Q3 		– Sell
-10
Closed -$1.84K – 4965
2017
Q2 		$1K Hold
10
– – ﹤0.01% 4695
2017
Q1 		$3K Buy
+10
New +$2.94K ﹤0.01% 4315
2016
Q4 		– Hold
0
– – – 4639
2016
Q3 		– Hold
0
– – – 4631
2016
Q2 		– Hold
0
– – – 4520

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Advisor Group's CSCI Position: Q4 2019 in Review

Advisor Group reduced its COSCIENS Biopharma Inc. Common Stock (CSCI) stake by 33% in Q4 2019, selling an estimated $466 and leaving 10 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5219.

Advisor Group first reported a position in CSCI in Q1 2017 and has held it in 7 quarters since. The position peaked at $7K in Q1 2019. 24 funds tracked by Wall St. Rank hold CSCI as of Q4 2019.

  • Advisor Group held 10 shares of COSCIENS Biopharma Inc. Common Stock worth $1K as of Q4 2019.
  • Advisor Group sold 5 COSCIENS Biopharma Inc. Common Stock shares in Q4 2019, an estimated $466.
  • COSCIENS Biopharma Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5219 holding.
  • Advisor Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2017 and has held it in 7 quarters since.
  • Advisor Group's COSCIENS Biopharma Inc. Common Stock position peaked at $7K in Q1 2019.
  • 24 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.